SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Turnover for the quarter ended June 2026 of Rs. 41580.00 millions increase by 58.94% from Rs. 26160.00 millions.A slender decline of -10.71% was recorded to Rs. 4920.00  millions from Rs. 5510.00 millions in the corresponding previous quarter.Operating profit for the quarter ended June 2026 rose to 15520.00 millions as compared to 9740.00 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 41580.00 26160.00 58.94 41580.00 26160.00 58.94 107120.00 96820.00 10.64
Other Income -210.00 -50.00 320.00 -210.00 -50.00 320.00 180.00 320.00 -43.75
PBIDT 15520.00 9740.00 59.34 15520.00 9740.00 59.34 40720.00 36070.00 12.89
Interest 2930.00 450.00 551.11 2930.00 450.00 551.11 3410.00 2130.00 60.09
PBDT 12380.00 9290.00 33.26 12380.00 9290.00 33.26 36610.00 33700.00 8.64
Depreciation 5750.00 1870.00 207.49 5750.00 1870.00 207.49 7640.00 7600.00 0.53
PBT 6630.00 7420.00 -10.65 6630.00 7420.00 -10.65 28970.00 26100.00 11.00
TAX 1710.00 1910.00 -10.47 1710.00 1910.00 -10.47 7050.00 7220.00 -2.35
Deferred Tax -950.00 -70.00 1257.14 -950.00 -70.00 1257.14 -150.00 1810.00 -108.29
PAT 4920.00 5510.00 -10.71 4920.00 5510.00 -10.71 21920.00 18880.00 16.10
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 1692.30 0.00
PBIDTM(%) 37.33 37.23 0.25 37.33 37.23 0.25 38.01 37.25 2.04

Torrent Pharma Share Price

5030.00 11.00 (0.22%)
04-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1960.00
Dr. Reddys Labs. 1160.65
Cipla 1450.00
Lupin 2376.00
Zydus Lifesciences 1118.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: